[Burimamid and metiamid, a new pharmacological principle].
D000818:Animals; D002415:Cats; D004305:Dose-Response Relationship, Drug; D005260:Female; D005753:Gastric Mucosa / Q000187:drug effects; D005769:Gastrointestinal Motility / Q000187:drug effects; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D006632:Histamine / Q000378:metabolism / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006801:Humans; D007082:Ileum / Q000187:drug effects; D007093:Imidazoles / Q000494:pharmacology; D066298:In Vitro Techniques; D008745:Methylation; D008968:Molecular Conformation; D010418:Pentagastrin / Q000037:antagonists & inhibitors; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D013440:Sulfides / Q000494:pharmacology; D013552:Swine; D013890:Thiourea / Q000494:pharmacology*; D014599:Uterus / Q000187:drug effects
D006634:Histamine H1 Antagonists; D007093:Imidazoles; D011955:Receptors, Drug; D013440:Sulfides; D006632:Histamine; D010418:Pentagastrin; D013890:Thiourea
Burimamid und Metiamid-ein neues pharmakologisches Prinzip